Depression Drugs Market
Depression Drugs Market Analysis By Drug Type (Generic Depression Drugs, Branded Depression Drugs), By Drug Class (Serotonin-norepinephrine Reuptake Inhibitors), By Disease (Major Depressive Disorder, Generalized Anxiety Disorder), By Distribution Channel - Regional Forecast 2031
Analysis of Depression Drugs market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT3215MR
- 03 Dec 2021
- Healthcare
- 288 Pages
- 87 Tables
- 50 Figures
Table of Content
- 1. Preface
- 2. Assumptions and Acronyms Used
- 3. Research Approach & Methodology
- 4. Executive Summary: Global Market
- 5. Market Overview
- 6. Market Dynamics
- 7. Global Market, by Drug Class
- 7.1. Atypical antipsychotics
- 7.2. Serotonin-norepinephrine reuptake inhibitors
- 7.3. Selective serotonin reuptake inhibitors
- 7.4. CNS stimulants
- 7.5. Others (Benzodiazepines and miscellaneous antidepressants)
- 8. Global Market, by Disease Type
- 8.1. Major Depressive Disorder
- 8.2. Schizophrenia and bipolar I disorder (manic depression)
- 8.3. SSRI induced
- 8.4. Others (attention deficit hyperactivity disorder and anxiety disorders)
- 9. Global Market, by Distribution Channel
- 9.1. Hospital pharmacies
- 9.2. Retail pharmacies
- 9.3. Online pharmacies
- 10. Global Market, by Region
- 10.1. North America
- 10.2. Europe
- 10.3. Asia Pacific
- 10.4. Latin America
- 10.5. Middle East & Africa
- 11. North America Market Analysis
- 12. Europe Market Analysis
- 13. Asia Pacific Market Analysis
- 14. Latin America Market Analysis
- 15. Middle East & Africa Market Analysis
- 16. Competition Landscape
- 16.1. Otsuka Pharmaceutical Co., Ltd.
- 16.2. Eli Lilly and Company
- 16.3. Pfizer, Inc.
- 16.4. AstraZeneca plc.
- 16.5. Novartis AG
- 16.6. GlaxoSmithKline plc
- 16.7. Takeda Pharmaceutical Company Ltd
- 16.8. Sebela Pharmaceutical Inc.
- 16.9. Allergan USA, Inc.
- 16.10. Johnson & Johnson
List Of Table
Table 01: Opportunity Map, by Drug Class, 2021
Table 02: Opportunity Map, by Disease Type, 2021
Table 03: Opportunity Map, by Distribution Channel, 2021
Table 04: Global Market Size (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 05: Global Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 06: Global Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 07: Global Market (US$ Mn) Forecast, by Region, 2020 to 2031
Table 08: North America Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 09: North America Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 10: North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 11: North America Market Size (US$ Mn) Forecast, by Country, 2020 to 2031
Table 12: U.S. Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 13: U.S. Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 14: U.S. Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 15: Canada Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 16: Canada Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 17: Canada Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 18: Europe Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 19: Europe Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 20: Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 21: Europe Market Size (US$ Mn) Forecast, by Country, 2020 to 2031
Table 22: Germany Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 23: Germany Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 24: Germany Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 25: France Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 26: France Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 27: France Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 28: Italy Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 29: Italy Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 30: Italy Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 31: Spain Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 32: Spain Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 33: Spain Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 34: U.K. Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 35: U.K. Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 36: U.K. Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 37: Rest of Europe Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 38: Rest of Europe Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 39: Rest of Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 40: Asia Pacific Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 41: Asia Pacific Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 42: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 43: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2020 to 2031
Table 44: China Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 45: China Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 46: China Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 47: Japan Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 48: Japan Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 49: Japan Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 50: India Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 51: India Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 52: India Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 53: Australia & New Zealand Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 54: Australia & New Zealand Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 55: Australia & New Zealand Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 56: Rest of Asia Pacific Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 57: Rest of Asia Pacific Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 58: Rest of Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 59: Latin America Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 60: Latin America Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 61: Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 62: Latin America Market Size (US$ Mn) Forecast, by Country, 2020 to 2031
Table 63: Brazil Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 64: Brazil Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 65: Brazil Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 66: Mexico Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 67: Mexico Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 68: Mexico Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 69: Rest of Latin America Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 70: Rest of Latin America Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 71: Rest of Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 72: Middle East & Africa Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 73: Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 74: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 75: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2020 to 2031
Table 76: GCC Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 77: GCC Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 78: GCC Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 79: South Africa Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 80: South Africa Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 81: South Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 82: Israel Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 83: Israel Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 84: Israel Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
Table 85: Rest of Middle East & Africa Market Size (US$ Mn) Forecast, by Drug Class, 2020 to 2031
Table 86: Rest of Middle East & Africa Market Size (US$ Mn) Forecast, by Disease Type, 2020 to 2031
Table 87: Rest of Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2020 to 2031
List Of Figures
Figure 01: Global Market Size (US$ Mn), by Drug Class, 2021 (A)
Figure 02: Global Market Revenue (%), 2021 (A)
Figure 03: Global Market Size (US$ Mn) Forecast, 2020 to 2031
Figure 04: Market Value Share, by Drug Class (2021)
Figure 05: Market Value Share, by Disease Type (2021)
Figure 06: Market Value Share, by Distribution Channel (2021)
Figure 07: Market Value Share, by Region (2021)
Figure 08: Global Market Value Share, by Valence, 2021 and 2031
Figure 09: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Atypical antipsychotics, 2021 to 2031
Figure 10: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by SNRI, 2021 to 2031
Figure 11: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by SSRI, 2021 to 2031
Figure 12: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by CNS stimulants, 2021 to 2031
Figure 13: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2021 to 2031
Figure 14: Global Market Value Share, by Disease Type, 2021 and 2031
Figure 15: Global Market Revenue (US$ Mn), by MDD, 2021 to 2025
Figure 16: Global Market Revenue (US$ Mn), by Schizophrenia and bipolar I disorder, 2021 to 2025
Figure 17: Global Market Revenue (US$ Mn), by SSRI induced, 2020 to 2031
Figure 18: Global Market Revenue (US$ Mn), by Others, 2020 to 2031
Figure 19: Global Market Value Share, by Distribution Channel, 2021 and 2031
Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital pharmacies, 2020 to 2031
Figure 21: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail pharmacies, 2020 to 2031
Figure 22: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online pharmacies, 2020 to 2031
Figure 23: Global Market Analysis, by Region, 2021 and 2031
Figure 24: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020 to 2031
Figure 25: North America Market Value Share, by Drug Class, 2021 and 2031
Figure 26: North America Market Value Share, by Disease Type, 2021 and 2031
Figure 27: North America Market Value Share, by Distribution Channel, 2021 and 2031
Figure 28: North America Market Value Share, by Country, 2021 and 2031
Figure 29: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020 to 2031
Figure 30: Europe Market Value Share, by Drug Class, 2021 and 2031
Figure 31: Europe Market Value Share, by Disease Type, 2021 and 2031
Figure 32: Europe Market Value Share, by Distribution Channel, 2021 and 2031
Figure 33: Europe Market Value Share, by Country/Sub Region, 2021 and 2031
Figure 34: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020 to 2031
Figure 35: Asia Pacific Market Value Share, by Drug Class, 2021 and 2031
Figure 36: Asia Pacific Market Value Share, by Disease Type, 2021 and 2031
Figure 37: Asia Pacific Market Value Share, by Distribution Channel, 2021 and 2031
Figure 38: Asia Pacific Market Value Share, by Country/Sub Region, 2021 and 2031
Figure 39: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020 to 2031
Figure 40: Latin America Market Value Share, by Drug Class, 2021 and 2031
Figure 41: Latin America Market Value Share, by Disease Type, 2021 and 2031
Figure 42: Latin America Market Value Share, by Distribution Channel, 2021 and 2031
Figure 43: Latin America Market Value Share, by Country, 2021 and 2031
Figure 44: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020 to 2031
Figure 45: Middle East & Africa Market Value Share, by Drug Class, 2021 and 2031
Figure 46: Middle East & Africa Market Value Share, by Disease Type, 2021 and 2031
Figure 47: Middle East & Africa Market Value Share, by Distribution Channel, 2021 and 2031
Figure 48: Middle East & Africa Market Value Share, by Country/Sub Region, 2021 and 2031
Figure 49: Sales Analysis, 2016 to 2020
Figure 50: Market Share, by Company, 2021
Depression Drugs Market